Advanced in Cardiomyopathy Due to Anthracyclines

Slawomir Mandziuk

Lublin, LU, PL 
Advanced in Cardiomyopathy Due to Anthracyclines
Lublin, LU, PL 
OverviewLocationsClinical Research

Overview

Slawomir Mandziuk practices in Lublin, Poland. Mandziuk is rated as an Advanced expert by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. Their top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Familial Benign Copper Deficiency, and Lung Cancer.

Their clinical research consists of co-authoring 38 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Cardiomyopathy Due to Anthracyclines.

Locations

Lublin, LU 20090, Poland
Other Locations
100 Krasnik Avenue, Krasnik, LU 20550, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
Enrollment Status: Active_not_recruiting
Publish Date: August 14, 2025
Intervention Type: Drug
Study Drug: Tepotinib
Study Phase: Phase 2
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
View 1 Less Clinical Trial

38 Total Publications

CAR-T in the Treatment of Solid Tumors-A Review of Current Research and Future Perspectives.
CAR-T in the Treatment of Solid Tumors-A Review of Current Research and Future Perspectives.
Journal: International journal of molecular sciences
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mandziuk's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile